What is Bristol-Myers Squibb's other — total revenues?

Bristol-Myers Squibb (BMY) reported other — total revenues of $257.00M in Q1 2026.

How has Bristol-Myers Squibb's other — total revenues changed year-over-year?

Bristol-Myers Squibb's other — total revenues increased by 17.9% year-over-year, from $218.00M to $257.00M.

What is the long-term trend for Bristol-Myers Squibb's other — total revenues?

Over 4 years (2021 to 2025), Bristol-Myers Squibb's other — total revenues has grown at a 6.3% compound annual growth rate (CAGR), from $852.00M to $1.09B.

What does other — total revenues mean?

Total revenue generated from geographic regions or business activities outside of the company's primary reporting segments.

Geographic · Total Revenues

Other — Total Revenues

Bristol-Myers Squibb Other — Total Revenues decreased by 16.8% to $257.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $218.00M to $257.00M. Over 4 years (FY 2021 to FY 2025), Other — Total Revenues shows an upward trend with a 6.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2016

Last reportedQ1 2026Apr 30, 2026

Rolls up toTotal Revenue

How to read this metric

An increase suggests successful market penetration or growth in secondary geographic regions, while a decrease may indicate a strategic withdrawal or declining demand in those specific areas.

Detailed definition

This metric represents the aggregate net sales generated from geographic regions or business activities not explicitly c...

Peer comparison

Peers in the pharmaceutical industry typically report 'Rest of World' or 'Other' segments to capture revenue from smaller international markets, though the composition of these segments varies significantly based on global footprint.

Metric ID: bmy_segment_other_total_revenues

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$191.00M	$276.00M	$221.00M	$227.00M	$192.00M	$215.00M	$200.00M	$155.00M	$175.00M	$185.00M	$184.00M	$199.00M	$176.00M	$271.00M	$350.00M	$218.00M	$270.00M	$290.00M	$309.00M	$257.00M
QoQ Change	—	+44.5%	-19.9%	+2.7%	-15.4%	+12.0%	-7.0%	-22.5%	+12.9%	+5.7%	-0.5%	+8.2%	-11.6%	+54.0%	+29.2%	-37.7%	+23.9%	+7.4%	+6.6%	-16.8%
YoY Change	—	—	—	—	+0.5%	-22.1%	-9.5%	-31.7%	-8.9%	-14.0%	-8.0%	+28.4%	+0.6%	+46.5%	+90.2%	+9.5%	+53.4%	+7.0%	-11.7%	+17.9%

Range$155.00M – $350.00M

CAGR+6.4%

Avg YoY Growth+9.3%

Median YoY Growth+0.5%

Similar Metrics at Other Companies

Restaurant Brands InternationalQSR View metric

BWX TechnologiesBWXT View metric

STERISSTE View metric

West Pharmaceutical ServicesWST View metric

Tapestry, Inc.TPR View metric

EquifaxEFX View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's other — total revenues?: Bristol-Myers Squibb (BMY) reported other — total revenues of $257.00M in Q1 2026.
How has Bristol-Myers Squibb's other — total revenues changed year-over-year?: Bristol-Myers Squibb's other — total revenues increased by 17.9% year-over-year, from $218.00M to $257.00M.
What is the long-term trend for Bristol-Myers Squibb's other — total revenues?: Over 4 years (2021 to 2025), Bristol-Myers Squibb's other — total revenues has grown at a 6.3% compound annual growth rate (CAGR), from $852.00M to $1.09B.
What does other — total revenues mean?: Total revenue generated from geographic regions or business activities outside of the company's primary reporting segments.